4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-24-000134
Director bought 431,940 shares at an average $17.07 ($7,373,527)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SPRINGER TIMOTHY A Director | 2024-11-14 | Purchase | +74,157 | $16.19 | $1,200,720 | 8,097,923 | D |
| SPRINGER TIMOTHY A Director | 2024-11-14 | Purchase | +22,242 | $16.97 | $377,436 | 8,120,165 | D |
| SPRINGER TIMOTHY A Director | 2024-11-15 | Purchase | +277,246 | $17.09 | $4,739,188 | 8,397,411 | D |
| SPRINGER TIMOTHY A Director | 2024-11-18 | Purchase | +38,114 | $17.96 | $684,447 | 8,435,525 | D |
| SPRINGER TIMOTHY A Director | 2024-11-18 | Purchase | +20,181 | $18.42 | $371,736 | 8,455,706 | D |
| Open-market purchases · 431,940 sh · avg $17.07 · $7,373,527 | |||||||
Loading xslF345X05/wk-form4_1731976543.xml…